|

Mirvetuximab soravtansine plus Bevacizumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MIRV

Pipeline

Phase 3: 1

Top Sponsors

  • AbbVie1

Indications

  • Peritoneal Cancer1
  • Fallopian Tube Cancer1
  • Ovarian Cancer1
  • Cancer1

Mobile, Alabama1 trial

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Usa Mitchell Cancer Institute /ID# 269661

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.